Biotech

All Articles

8 months after a $213M fundraise, genetics editor Tome helps make cuts

.After increasing $213 thousand in 2023-- among the year's largest personal biotech shots-- Tome Bio...

BioMarin constructs exec staff along with biotech veterinarians-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of significant leadership hirings, shooting...

Biopharma Q2 VC hit highest degree because '22, while M&ampA slowed

.Financial backing funding in to biopharma rose to $9.2 billion across 215 sell the second one-fourt...

Bicara, Zenas find IPOs to drive late-phase assets towards market

.Bicara Rehabs as well as Zenas Biopharma have given fresh incentive to the IPO market along with fi...

Genentech to finalize cancer immunology investigation division

.Genentech is going to close its cancer immunology investigation division, and device head and promi...

Kezar goes down solid growth but to confirm its well worth in period 1 trial

.Kezar Lifestyle Sciences is actually losing its unpromising stage 1 solid cyst medicine as the biot...

Acelyrin loses izokibep, drops 3rd of personnel

.Regardless of izokibep sustaining its newly found winning streak in the medical clinic, Acelyrin is...

Rivus' phase 2 obesity-related cardiac arrest trial hits endpoint

.Rivus Pharmaceuticals has actually plumped up the customers of its own fat-busting, muscle-sparing ...

Ovid halts preclinical job, IV program after soticlestat neglect

.Ovid Rehab presently exposed final month that it was actually trimming its own head count as the fi...

Eli Lilly opens $700M nucleic acid R&ampD center in Boston Seaport

.Eli Lilly has opened a $700 thousand R&ampD facility in the Boston ma Seaport, boosting its RNA and...